Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

China · Delayed Price · Currency is CNY

58.63

-0.97 (-1.63%)

Apr 16, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	451.87M	388.79M	447.46M	369.44M	282.35M
Pharmaceuticals Growth	16.22%	-13.11%	21.12%	30.85%	47.63%
Total	451.87M	388.79M	447.46M	369.44M	282.35M
Total Growth	16.22%	-13.11%	21.12%	30.85%	47.63%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	288.01M	262.06M	-	-	-
China Growth	9.90%	-	-	-	-
Export	163.87M	126.73M	-	-	-
Export Growth	29.30%	-	-	-	-
Total	451.87M	388.79M	-	-	-
Total Growth	16.22%	-	-	-	-

Source: S&P Global Market Intelligence.